Hsbc Holdings PLC Novo Cure LTD Transaction History

Hsbc Holdings PLC

$168 Billion
Q4 2024

A detailed history of Hsbc Holdings PLC transactions in Novo Cure LTD stock. As of the latest transaction made, Hsbc Holdings PLC holds 49,725 shares of NVCR stock, worth $952,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares

49,725

Previous 58,794 15.43%

Holding current value

$952,233

Previous $918,000 61.33%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$14.54 - $33.41 $131,863 - $302,995	-9,069 Reduced 15.43%	49,725 $1.48 Million
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $234,524 - $350,660	-15,024 Reduced 20.35%	58,794 $918,000
Q2 2024 Aug 12, 2024	SELL	$11.83 - $24.05 $893,519 - $1.82 Million	-75,530 Reduced 50.57%	73,818 $1.26 Million
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $607,201 - $845,290	48,889 Added 48.67%	149,348 $2.33 Million
Q4 2023 Feb 12, 2024	BUY	$11.13 - $15.78 $715,035 - $1.01 Million	64,244 Added 177.4%	100,459 $1.5 Million
Q3 2023 Nov 13, 2023	BUY	$16.15 - $42.35 $161,209 - $422,737	9,982 Added 38.05%	36,215 $584,000
Q2 2023 Aug 11, 2023	SELL	$40.29 - $82.51 $12,167 - $24,918	-302 Reduced 1.14%	26,233 $1.09 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $1.25 Million - $2.63 Million	22,156 Added 505.96%	26,535 $1.6 Million
Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $896,551 - $1.2 Million	-14,013 Reduced 76.19%	4,379 $321,000
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $192,071 - $253,035	2,825 Added 18.15%	18,392 $1.43 Million
Q2 2022 Aug 11, 2022	BUY	$56.6 - $89.9 $881,092 - $1.4 Million	15,567 New	15,567 $1.1 Million
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $702,363 - $1.18 Million	-6,046 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $448,967 - $776,671	3,443 Added 132.27%	6,046 $1.34 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $143,967 - $220,597	-1,160 Reduced 30.83%	2,603 $344,000
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $113,842 - $176,752	1,015 Added 36.94%	3,763 $651,000
Q3 2020 Nov 12, 2020	BUY	$58.05 - $111.31 $159,521 - $305,879	2,748 New	2,748 $309,000
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $467,104 - $738,487	-7,551 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$42.22 - $63.23 $107,618 - $161,173	2,549 Added 50.96%	7,551 $477,000
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $159,863 - $280,712	5,002 New	5,002 $241,000

Others Institutions Holding NVCR

# of Institutions

290

Shares Held

75.6M

Call Options Held

1.77M

Put Options Held

538K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.01B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Novo Cure LTD Transaction History